Diode Array Peak Purity: What a Spectral Check Proves for Peptides
A single, symmetrical HPLC peak looks reassuring, but a peak shape cannot tell you whether one compound or two passed the detector at that moment. Diode array peak purity analysis tries to answer that question from UV spectra recorded across the peak. It is widely reported, frequently misunderstood, and for peptides in particular it has blind spots that anyone reviewing a certificate or an in-house chromatogram should know about. This guide explains how the check works, what the software’s numbers mean, and why a pass carries much less weight than a fail.
From one wavelength to a spectrum every moment
A conventional variable-wavelength detector measures absorbance at a single wavelength. A diode-array detector (DAD, sometimes called a photodiode-array or PDA detector) passes the full beam through the flow cell and then spreads it across an array of photodiodes. It records absorbance at every wavelength in its range simultaneously, many times per second.
So instead of one trace, the run produces a three-dimensional data set: time, wavelength and absorbance. Every point across a peak has its own UV spectrum, and peak purity analysis works entirely from those spectra.
The principle behind diode array peak purity
For a single compound, the shape of its UV spectrum stays the same regardless of concentration; only its height changes. If a peak contains only one compound, the spectra taken on the leading edge, at the apex and on the trailing edge should all share one shape once they are scaled to the same height.
If a second compound with a different spectrum co-elutes, and it is not perfectly centred under the first, the mixture changes across the peak. The front might be richer in one species and the tail in the other. That changing mixture shows up as a changing spectral shape, which the software can detect.
How the software turns spectra into a verdict
Different data systems calculate and present the result differently, and the numbers are not interchangeable between them. The common forms are:
- An angle compared with a threshold. Each spectrum is treated as a vector, and the angle between spectra measures how different their shapes are. A threshold angle, estimated from baseline noise, sets how much difference noise alone could produce. An angle below the threshold means no difference beyond noise was found.
- A similarity or match factor. A score where a perfect match is the maximum, often 1,000, with a user-set pass limit.
- A purity curve or plot. The spectral difference plotted point by point across the peak, showing where any mismatch sits. This is usually more informative than any single summary number.
Settings such as the wavelength range used, background correction and the noise estimate all change the outcome, so a result is only interpretable alongside those settings.
Why peptides are a hard case
Peptide UV spectra are dominated by a few chromophores. The amide backbone absorbs strongly below about 220 nm, where spectra are steep and fairly featureless. Tryptophan, tyrosine and phenylalanine add structure between roughly 250 and 290 nm. Most other residues contribute little that distinguishes them.
As a result, the related substances that tend to hide under a peptide peak usually share its spectrum almost exactly:
- deletion sequences missing a non-aromatic residue
- deamidated forms, where asparagine becomes aspartate or isoaspartate
- diastereomers from racemisation during synthesis
- truncations that keep all the aromatic residues
A peak containing any of these alongside the target can pass the spectral test perfectly. There are exceptions worth knowing. Oxidation of tryptophan produces species such as kynurenine and N-formylkynurenine, which absorb at longer wavelengths than intact tryptophan. An impurity that has lost or gained an aromatic residue also changes the spectrum. In those cases the test has something to find.
Conditions for a meaningful result
| Requirement | What goes wrong without it |
|---|---|
| Adequate signal | Noisy spectra raise the noise threshold until almost any peak passes, so small peaks prove little |
| No detector saturation | Above the linear range, apex spectra flatten or skew, so even a single compound may be flagged |
| Proper background correction | Mobile-phase absorbance changing through a gradient, especially with TFA at low wavelengths, adds spectral drift of its own |
| A spectrally different impurity | Impurities sharing the target’s spectrum, or lacking any UV absorbance, cannot be flagged |
| Partial, not perfect, co-elution | Two species eluting with identical profiles give a constant mixture spectrum that cannot be distinguished from a pure one |
Reading a pass and a fail
The evidence is asymmetric. A fail, obtained with good signal and a sound baseline, is strong evidence that the peak holds more than one component. That finding deserves follow-up.
A pass is weak evidence. It shows that no spectrally different component was detected under those conditions and at that signal level. It does not show that the peak is one compound. A certificate or report that describes a spectral pass as proof of a single species is claiming more than the technique can deliver.
What settles co-elution, and what to ask about a lot
Two approaches go further than spectral purity:
- An orthogonal separation. A different stationary phase, a different pH or a different mode such as hydrophilic interaction chromatography sorts molecules on another property and often pulls apart pairs that co-eluted the first time.
- Mass spectrometric detection across the peak. LC-MS distinguishes species by mass, so it catches deletions, truncations and many modifications that are invisible to a UV spectrum. Deamidation, at under 1 Da, still needs good resolution or chromatographic separation.
When reviewing lots in volume, ask whether a stated peak purity result names its metric, its threshold and the wavelength range used, and whether a purity plot is available. Keep those settings fixed when comparing one lot with the next, or differences in the result may reflect the software rather than the material. The broader issue is covered in co-elution and peptide purity, and the chromatogram itself in reading an HPLC chromatogram.
All material sold by Bulk Peptides is for research in the laboratory, in vitro and analytical settings only, and is not intended for people or animals.
